These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275 [TBL] [Abstract][Full Text] [Related]
3. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342 [TBL] [Abstract][Full Text] [Related]
4. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2. Inamori K; Hara Y; Willer T; Anderson ME; Zhu Z; Yoshida-Moriguchi T; Campbell KP Glycobiology; 2013 Mar; 23(3):295-302. PubMed ID: 23125099 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417 [TBL] [Abstract][Full Text] [Related]
7. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy. Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP Elife; 2023 Feb; 12():. PubMed ID: 36723429 [TBL] [Abstract][Full Text] [Related]
8. LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE. Ashikov A; Buettner FF; Tiemann B; Gerardy-Schahn R; Bakker H Glycobiology; 2013 Mar; 23(3):303-9. PubMed ID: 23135544 [TBL] [Abstract][Full Text] [Related]
9. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448 [TBL] [Abstract][Full Text] [Related]
10. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan. Nakagawa N; Takematsu H; Oka S Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439 [TBL] [Abstract][Full Text] [Related]
11. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. Willer T; Inamori K; Venzke D; Harvey C; Morgensen G; Hara Y; Beltrán Valero de Bernabé D; Yu L; Wright KM; Campbell KP Elife; 2014 Oct; 3():. PubMed ID: 25279699 [TBL] [Abstract][Full Text] [Related]
12. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1. Righino B; Bozzi M; Pirolli D; Sciandra F; Bigotti MG; Brancaccio A; De Rosa MC J Chem Inf Model; 2020 Jun; 60(6):3145-3156. PubMed ID: 32356985 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of the matriglycan hexasaccharide, -3Xylα1-3GlcAβ1-trimer and its interaction with laminin. Tamura T; Omura Y; Kotera K; Ito R; Ohno S; Manabe N; Yamaguchi Y; Tamura JI Org Biomol Chem; 2022 Nov; 20(43):8489-8500. PubMed ID: 36268609 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V. Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044 [TBL] [Abstract][Full Text] [Related]
15. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806 [TBL] [Abstract][Full Text] [Related]
16. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE. Fujimura K; Sawaki H; Sakai T; Hiruma T; Nakanishi N; Sato T; Ohkura T; Narimatsu H Biochem Biophys Res Commun; 2005 Apr; 329(3):1162-71. PubMed ID: 15752776 [TBL] [Abstract][Full Text] [Related]
17. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan. Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719 [TBL] [Abstract][Full Text] [Related]
18. In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE. Bhattacharya S; Das A; Bagchi A Comput Biol Chem; 2016 Oct; 64():313-321. PubMed ID: 27565399 [TBL] [Abstract][Full Text] [Related]
19. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003 [TBL] [Abstract][Full Text] [Related]